176 related articles for article (PubMed ID: 19618426)
1. Assay of diffusion of different botulinum neurotoxin type a formulations injected in the mouse leg.
Carli L; Montecucco C; Rossetto O
Muscle Nerve; 2009 Sep; 40(3):374-80. PubMed ID: 19618426
[TBL] [Abstract][Full Text] [Related]
2. Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®.
Frevert J
Drugs R D; 2010; 10(2):67-73. PubMed ID: 20698714
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of botulinum toxin: differences between type A preparations.
Rosales RL; Bigalke H; Dressler D
Eur J Neurol; 2006 Feb; 13 Suppl 1():2-10. PubMed ID: 16417591
[TBL] [Abstract][Full Text] [Related]
4. Dramatic changes in muscle contractile and structural properties after 2 botulinum toxin injections.
Minamoto VB; Suzuki KP; Bremner SN; Lieber RL; Ward SR
Muscle Nerve; 2015 Oct; 52(4):649-57. PubMed ID: 25598004
[TBL] [Abstract][Full Text] [Related]
5. Botulinum Neurotoxin A injections influence stretching of the gastrocnemius muscle-tendon unit in an animal model.
Haubruck P; Mannava S; Plate JF; Callahan MF; Wiggins WF; Schmidmaier G; Tuohy CJ; Saul KR; Smith TL
Toxins (Basel); 2012 Aug; 4(8):605-19. PubMed ID: 23012650
[TBL] [Abstract][Full Text] [Related]
6. AbobotulinumtoxinA (Dysport
Field M; Splevins A; Picaut P; van der Schans M; Langenberg J; Noort D; Snyder D; Foster K
Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30551641
[TBL] [Abstract][Full Text] [Related]
7. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions.
Aoki KR; Guyer B
Eur J Neurol; 2001 Nov; 8 Suppl 5():21-9. PubMed ID: 11851731
[TBL] [Abstract][Full Text] [Related]
9. Characterization of diffusion and duration of action of a new botulinum toxin type A formulation.
Stone HF; Zhu Z; Thach TQ; Ruegg CL
Toxicon; 2011 Aug; 58(2):159-67. PubMed ID: 21658400
[TBL] [Abstract][Full Text] [Related]
10. Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection.
Cai BB; Francis J; Brin MF; Broide RS
Neuroscience; 2017 Jun; 352():155-169. PubMed ID: 28389376
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A (Botox) and sweating-dose efficacy and comparison to other BoNT preparations.
Schlereth T; Mouka I; Eisenbarth G; Winterholler M; Birklein F
Auton Neurosci; 2005 Feb; 117(2):120-6. PubMed ID: 15664565
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal neural cell adhesion molecule antibody prolongs the effective duration time of botulinum toxin in decreasing muscle strength.
Guo Y; Pan L; Liu W; Pan Y; Nie Z; Jin L
Neurol Sci; 2015 Nov; 36(11):2019-25. PubMed ID: 26150164
[TBL] [Abstract][Full Text] [Related]
13. The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical use.
Wortzman MS; Pickett A
Aesthet Surg J; 2009 Nov; 29(6 Suppl):S34-42. PubMed ID: 19945003
[TBL] [Abstract][Full Text] [Related]
14. How muscles recover from paresis and atrophy after intramuscular injection of botulinum toxin A: Study in juvenile rats.
Shen J; Ma J; Lee C; Smith BP; Smith TL; Tan KH; Koman LA
J Orthop Res; 2006 May; 24(5):1128-35. PubMed ID: 16602109
[TBL] [Abstract][Full Text] [Related]
15. Comparative Pharmacodynamics of Three Different Botulinum Toxin Type A Preparations following Repeated Intramuscular Administration in Mice.
Byun J; Kwak S; Kwon JH; Shin M; Lee DK; Rhee CH; Kang WH; Oh JW; Cruz DJM
Toxins (Basel); 2022 May; 14(6):. PubMed ID: 35737026
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxin serotypes A and B preparations have different safety margins in preclinical models of muscle weakening efficacy and systemic safety.
Roger Aoki K
Toxicon; 2002 Jul; 40(7):923-8. PubMed ID: 12076646
[TBL] [Abstract][Full Text] [Related]
17. More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.
Mazzocchio R; Caleo M
Neuroscientist; 2015 Feb; 21(1):44-61. PubMed ID: 24576870
[TBL] [Abstract][Full Text] [Related]
18. The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes.
Marinelli S; Vacca V; Ricordy R; Uggenti C; Tata AM; Luvisetto S; Pavone F
PLoS One; 2012; 7(10):e47977. PubMed ID: 23110146
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution.
Tang-Liu DD; Aoki KR; Dolly JO; de Paiva A; Houchen TL; Chasseaud LF; Webber C
Toxicon; 2003 Oct; 42(5):461-9. PubMed ID: 14529727
[TBL] [Abstract][Full Text] [Related]
20. Electromyographic quantification of the paralysing effect of botulinum toxin in the sternocleidomastoid muscle.
Dressler D; Rothwell JC
Eur Neurol; 2000; 43(1):13-6. PubMed ID: 10798896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
